• No results found

Molecular, biochemical end clinical aspects of peroxisomes biogenesis disorders - Contents

N/A
N/A
Protected

Academic year: 2021

Share "Molecular, biochemical end clinical aspects of peroxisomes biogenesis disorders - Contents"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Molecular, biochemical end clinical aspects of peroxisomes biogenesis

disorders

Gootjes, J.

Publication date

2004

Link to publication

Citation for published version (APA):

Gootjes, J. (2004). Molecular, biochemical end clinical aspects of peroxisomes biogenesis

disorders.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

(2)

Contents s

Chapterr 1

Chapterr 2

Chapterr 3

Chapterr 4

Chapterr 5

;

--Chapterr 6

|IIIIWIIIIII,'llrHIHIll)>>

f.-ChaptejSfE E

Chapterr 8

Summary y

Samenvatting g

Dankwoord d

CV V

Generall introduction

Biochemicall markers predicting survival in peroxisome biogenesiss disorders

Novell mutations in the PEX2 gene of four unrelated patientss with a peroxisome biogenesis disorder

Novell mutations in the PEX12 gene of patients with a peroxisomee biogenesis disorder

Identificationn of the molecular defect in patients with peroxisomall mosaicism using a novel method involvingg culturing of cells at 40°C: implications for otherr inborn errors of metabolism

Reinvestigationn of trihydroxycholestanoic acidemia: a peroxisomee biogenesis disorder as true defect

Rapidd diagnosis of peroxisomal biogenesis disorders byy means of immunofluorescence microscopy in lymphocytes s

Mutationall spectrum of peroxisome biogenesis disorders s

Referenties

GERELATEERDE DOCUMENTEN

Topographic maps for LI (left) and HI (right), at Pz, for No-Go trials in the Go/No-Go task. Visual representation of one trial in the SSRT. a blue circle) on Go trials (75%

Stopping the “World’s Greatest Threat”: Canadian Policy and Rhetoric towards the Iranian Nuclear Program during Stephen Harper’s Conservative Government, 2006-2015.. by

I think joy, and like, you know, just taking care of yourself and the people around you is really important to this work because we’re in it for the long haul. we have to take care

German’s report, the Corporate Registration program plays a key role in GPEB’s regulatory framework, and is a principal mechanism through which GPEB maintains control over

Britton (1997) concluded that race and gender are contributing factors in stress and further identified the need for future researchers to explore how these intersections

These structural investigations into the mechanism for germ-line antibody recognition of carbohydrate antigens utilizing chlamydial-specific and anti-lipid A antibodies

Our structural analysis revealed that while the N- terminal region of TbFam50.360 adopted a three-helical structure similar to previously characterized trypanosome surface

I showed that data on the structural differences between the native and aggregated forms of the prion protein, obtained from multiple structural proteomics approaches